SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Syngene International

BSE: 539268 30 Apr 2025
Healthcare
₹ 627.7
Syngene International Limited specializes in Healthcare Research- Analytics & Technology within the Healthcare sector.

Syngene International - Share Price & Details

Market Cap
₹25,320
High /Low
961.0 / 608.0
Stock P/E
53.6
Book Value
₹117.0
Dividend Yield
0.2
ROCE
13.5
ROE
₹10.5
Face Value
10.0
PEG Ratio
9.48
EVEBITDA
₹22.6
Debt
578
CMP / FCF
60.5
Debt to equity
₹0.12
NP Ann
496
High price all time
961.0
Piotroski score
₹6.0
Graham Number
180.0
No. Eq. Shares
40.2
Net CF
₹281
Net profit
496
Price to book value
5.36
Interest Coverage
₹12.8
Low price all time
148.0
Industry PE
44.2
Reserves
₹4,324
Free Cash Flow
₹398

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic0.700.190.61NA3.1123.9
Triochem Products Ltd.,4.590.88NA3.600
Syngene International Limited8951123187713.0625,32053.6
J.B.CHEMICALS & PHARMACEUTICAL9,714.901,624.909,634.9010.242477838.7
Gland Pharma Limited14425.462046.9213840.5212.422328133.0

Peer Comparison Chart


About Syngene International

Syngene International Limited, with Security Code 539268, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Syngene International Stock Declines 3.68% Amid Broader Market Weakness

(13 Jan 2025)
Syngene International, a prominent player in the pharmaceuticals and drugs sector, experienced a decline of 3.68% on January 13, 2025.
Read more →

SYNGENE INTERNATIONAL Share Price Today Down 5%

(13 Jan 2025)
SYNGENE INTERNATIONAL share price has plunged 5% and is presently trading at Rs 818.6. Meanwhile, the BSE HEALTHCARE index is at 42,992.4...
Read more →

Syngene faces revised tax demand following rectification order

(26 Dec 2024)
Syngene International Limited: Syngene International Ltd. received a rectification order from the Assessing Officer for AY 2017-18 and...
Read more →

Syngene International Ltd.

(21 Dec 2024)
Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical,...
Read more →

Stock Radar: Syngene trades near crucial 100-EMA, down 10% from highs; time to buy?

(20 Dec 2024)
Syngene International's stock is displaying an Ascending Triangle pattern on the daily chart, a bullish signal that suggests the potential...
Read more →

Syngene International Limited's (NSE:SYNGENE) largest shareholders are public companies with 55% ownership, institutions own 27%

(12 Dec 2024)
Key Insights The considerable ownership by public companies in Syngene International indicates that they collectively...
Read more →